Chison Medical Technologies Co., Ltd. (SHA:688358)
33.68
-1.01 (-2.91%)
May 21, 2026, 3:00 PM CST
SHA:688358 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,005 | 1,010 | 985.62 | 688.77 | 446.2 | 445.87 |
Trading Asset Securities | - | 58 | 115.17 | 340.55 | 581.01 | 580.43 |
Cash & Short-Term Investments | 1,005 | 1,068 | 1,101 | 1,029 | 1,027 | 1,026 |
Cash Growth | -10.45% | -3.02% | 6.94% | 0.21% | 0.09% | -1.98% |
Accounts Receivable | 220.36 | 189.28 | 161.69 | 154.55 | 93.52 | 135.81 |
Other Receivables | 4.16 | 4.28 | 2.44 | 3.47 | 3.68 | 1.65 |
Receivables | 224.52 | 193.56 | 164.14 | 158.02 | 97.2 | 137.46 |
Inventory | 139.49 | 129.35 | 126.33 | 135.93 | 196.96 | 99.45 |
Other Current Assets | 15.8 | 16.12 | 13.78 | 18.06 | 17.46 | 7.11 |
Total Current Assets | 1,385 | 1,407 | 1,405 | 1,341 | 1,339 | 1,270 |
Property, Plant & Equipment | 153.1 | 151.71 | 157.72 | 143.24 | 137.33 | 94.48 |
Other Intangible Assets | 21.36 | 21.57 | 20.43 | 21.07 | 22.06 | 22.54 |
Long-Term Deferred Tax Assets | 10.72 | 11.18 | 8.45 | 9.27 | 10.21 | 7.67 |
Long-Term Deferred Charges | 0.17 | - | 0.88 | 0.69 | 0 | 0.13 |
Other Long-Term Assets | 4.14 | 3.84 | 4.49 | 6.89 | 5.5 | 2.94 |
Total Assets | 1,574 | 1,595 | 1,597 | 1,522 | 1,514 | 1,398 |
Accounts Payable | 84.07 | 75.6 | 68.32 | 66.91 | 92.09 | 53.89 |
Accrued Expenses | 10.43 | 31.99 | 33.12 | 32.09 | 36.98 | 32.75 |
Current Portion of Leases | - | 1.28 | 3.86 | 4.02 | 0.31 | 0.58 |
Current Income Taxes Payable | 8.24 | 7.69 | 6.59 | 3.26 | 2.15 | 3.84 |
Current Unearned Revenue | 23.78 | 31.09 | 30.7 | 16 | 22.99 | 25.21 |
Other Current Liabilities | 6.9 | 48.34 | 24.19 | 16.11 | 33.94 | 23.45 |
Total Current Liabilities | 135.68 | 195.99 | 166.79 | 138.39 | 188.47 | 139.73 |
Long-Term Leases | 4.23 | 1.86 | 2.67 | 6.32 | 5.8 | 0.79 |
Long-Term Unearned Revenue | 1.22 | 0.22 | 0.81 | 2.3 | 1.85 | 3.54 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.15 | - |
Other Long-Term Liabilities | 13.31 | 13.36 | 6.16 | 6.41 | 4.15 | 8.43 |
Total Liabilities | 154.44 | 211.43 | 176.42 | 153.42 | 200.42 | 152.49 |
Common Stock | 112.13 | 112.13 | 112.12 | 112.12 | 112.12 | 80 |
Additional Paid-In Capital | 899.46 | 899.04 | 903.81 | 905.22 | 907.56 | 937.6 |
Retained Earnings | 430.06 | 384.03 | 413.05 | 362.04 | 294.05 | 228.2 |
Treasury Stock | - | - | -10.09 | -10.09 | - | - |
Comprehensive Income & Other | -22.05 | -11.71 | 1.7 | -0.22 | -0.22 | -0.22 |
Shareholders' Equity | 1,420 | 1,383 | 1,421 | 1,369 | 1,314 | 1,246 |
Total Liabilities & Equity | 1,574 | 1,595 | 1,597 | 1,522 | 1,514 | 1,398 |
Total Debt | 6.49 | 3.14 | 6.53 | 10.34 | 6.11 | 1.37 |
Net Cash (Debt) | 998.24 | 1,064 | 1,094 | 1,019 | 1,021 | 1,025 |
Net Cash Growth | -10.57% | -2.72% | 7.39% | -0.21% | -0.37% | -2.11% |
Net Cash Per Share | 8.92 | 9.50 | 9.81 | 9.25 | 9.07 | 9.11 |
Filing Date Shares Outstanding | 112.26 | 112.13 | 111.87 | 112.12 | 112.12 | 112 |
Total Common Shares Outstanding | 112.26 | 112.13 | 111.87 | 112.12 | 112.12 | 112 |
Working Capital | 1,249 | 1,211 | 1,238 | 1,203 | 1,150 | 1,131 |
Book Value Per Share | 12.65 | 12.34 | 12.70 | 12.21 | 11.71 | 11.12 |
Tangible Book Value | 1,398 | 1,362 | 1,400 | 1,348 | 1,291 | 1,223 |
Tangible Book Value Per Share | 12.46 | 12.15 | 12.52 | 12.02 | 11.52 | 10.92 |
Buildings | - | 73.26 | 73.38 | 73.28 | 67.53 | 66.75 |
Machinery | - | 83.13 | 81.95 | 75.2 | 71.87 | 67.29 |
Construction In Progress | - | 79.79 | 76.3 | 55.56 | 52.33 | 8.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.